<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Mid Cap Value Fund Investor Class — News on 6ix</title>
    <link>https://6ix.com/company/mid-cap-value-fund-investor-class</link>
    <description>Latest news and press releases for Mid Cap Value Fund Investor Class on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Wed, 22 Apr 2026 04:00:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/mid-cap-value-fund-investor-class" rel="self" type="application/rss+xml" />
    <item>
      <title>Amaze Announces Launch of Amaze Live as Its Next-Generation Multi-Channel Live Shopping Platform</title>
      <link>https://6ix.com/company/mid-cap-value-fund-investor-class/news/amaze-announces-launch-of-amaze-live-as-its-next-generation-multi-channel-live-shopping-platform</link>
      <guid isPermaLink="true">https://6ix.com/company/mid-cap-value-fund-investor-class/news/amaze-announces-launch-of-amaze-live-as-its-next-generation-multi-channel-live-shopping-platform</guid>
      <pubDate>Wed, 22 Apr 2026 04:00:00 GMT</pubDate>
      <description>Amaze Live Enables Creators and Brands to Sell Live Across Any Channel, Without Being Locked Into a Single Platform NEWPORT BEACH, Calif., April 22, 2026</description>
    </item>
    <item>
      <title>Press Release: Sanofi&apos;s Tzield approved in the US to delay the onset of stage 3 type 1 diabetes in young children</title>
      <link>https://6ix.com/company/mid-cap-value-fund-investor-class/news/press-release-sanofis-tzield-approved-in-the-us-to-delay-the-onset-of-stage-3-type-1-diabetes-in-young-children-3</link>
      <guid isPermaLink="true">https://6ix.com/company/mid-cap-value-fund-investor-class/news/press-release-sanofis-tzield-approved-in-the-us-to-delay-the-onset-of-stage-3-type-1-diabetes-in-young-children-3</guid>
      <pubDate>Wed, 22 Apr 2026 04:00:00 GMT</pubDate>
      <description>Sanofi&apos;s Tzield approved in the US to delay the onset of stage 3 type 1 diabetes in young children Expanded approval includes children aged one year and above</description>
    </item>
    <item>
      <title>MHIEC Completes Improvement of Core Equipment at Municipal Solid Waste Incineration Facility in Sendai City</title>
      <link>https://6ix.com/company/mid-cap-value-fund-investor-class/news/mhiec-completes-improvement-of-core-equipment-at-municipal-solid-waste-incineration-facility-in-sendai-city</link>
      <guid isPermaLink="true">https://6ix.com/company/mid-cap-value-fund-investor-class/news/mhiec-completes-improvement-of-core-equipment-at-municipal-solid-waste-incineration-facility-in-sendai-city</guid>
      <pubDate>Tue, 21 Apr 2026 04:00:00 GMT</pubDate>
      <description>TOKYO, Apr 22, 2026 - (JCN Newswire) - - Mitsubishi Heavy Industries Environmental &amp; Chemical Engineering Co., Ltd. (MHIEC), a part of Mitsubishi Heavy</description>
    </item>
    <item>
      <title>CIVISTA BANCSHARES, INC. ANNOUNCES SECOND QUARTER COMMON DIVIDEND</title>
      <link>https://6ix.com/company/mid-cap-value-fund-investor-class/news/civista-bancshares-inc-announces-second-quarter-common-dividend-1</link>
      <guid isPermaLink="true">https://6ix.com/company/mid-cap-value-fund-investor-class/news/civista-bancshares-inc-announces-second-quarter-common-dividend-1</guid>
      <pubDate>Tue, 21 Apr 2026 04:00:00 GMT</pubDate>
      <description>SANDUSKY, Ohio, April 21, 2026 /PRNewswire/ -- Civista Bancshares, Inc. (NASDAQ:CIVB) (&quot;Civista&quot;) announces that the Board of Directors has approved and</description>
    </item>
    <item>
      <title>908 Devices Appoints Kola Otitoju as Chief Business &amp; Strategy Officer and Announces an Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)</title>
      <link>https://6ix.com/company/mid-cap-value-fund-investor-class/news/908-devices-appoints-kola-otitoju-as-chief-business-and-strategy-officer-and-announces-an-inducement-grant-under-nasdaq-listing-rule-5635c4-21</link>
      <guid isPermaLink="true">https://6ix.com/company/mid-cap-value-fund-investor-class/news/908-devices-appoints-kola-otitoju-as-chief-business-and-strategy-officer-and-announces-an-inducement-grant-under-nasdaq-listing-rule-5635c4-21</guid>
      <pubDate>Tue, 21 Apr 2026 04:00:00 GMT</pubDate>
      <description>BURLINGTON, Mass.--(BUSINESS WIRE)-- 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces the</description>
    </item>
  </channel>
</rss>